Hisun Pharmaceuticals USA to Attend CPHI Milan 2026

September 11, 2026

Hisun Pharmaceuticals USA to Attend CPHI Milan 2026

Bridgewater, NJ – September 2026 – Hisun Pharmaceuticals USA Inc. is pleased to announce its participation in CPHI Milan 2026, one of the world’s leading pharmaceutical industry events, taking place from October 6–8, 2026, at Fiera Milano Rho in Milan, Italy.

As a U.S. subsidiary of Zhejiang Hisun Pharmaceutical Co., Ltd., Hisun Pharmaceuticals USA is committed to expanding access to high-quality pharmaceutical products and building long-term partnerships across the global healthcare industry. CPHI Milan will provide an important opportunity for the Hisun team to connect with existing and prospective partners, exchange industry insights, and explore new opportunities for collaboration.

During the three-day event, representatives from Hisun Pharmaceuticals USA will be available to discuss the company’s capabilities, product portfolio, and potential business opportunities in the U.S. and global pharmaceutical markets.

Visitors and industry partners are warmly invited to meet the Hisun team at Booth 14C26.

Event Details

Event: CPHI Milan 2026
Date: October 6–8, 2026
Venue: Fiera Milano Rho, Milan, Italy
Booth: 14C26

To schedule a meeting with the Hisun Pharmaceuticals USA team during CPHI Milan, please contact:

Terry Bai, Director of BD
Email: terry.bai@hisunusa.com

Jack Broeker, API Sales Manager
Email: jack.broeker@hisunusa.com

We look forward to meeting our partners and colleagues in Milan and exploring opportunities to create greater value for patients and the pharmaceutical industry worldwide.

Passion for Life, Light for Health.